Baxalta (NYSE: BXLT) and Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), announced the initiation of a pivotal clinical trial in patients with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE